Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. Mullerad is active.

Publication


Featured researches published by M. Mullerad.


The Journal of Urology | 2003

The Value of Quantitative 99MTechnetium Dimercaptosuccinic Acid Renal Scintigraphy For Predicting Postoperative Renal Insufficiency In Patients Undergoing Nephrectomy

M. Mullerad; Alexander Kastin; Elias Issaq; Boaz Moskovitz; David Groshar; Ofer Nativ

PURPOSE Radical nephrectomy is a routine urological practice. However, little is known about the use of dimercapto-succinic acid (DMSA) scan to evaluate compensatory changes after surgery and its ability to identify patient at risk for postoperative chronic renal failure or insufficiency. We predicted remaining kidney function using DMSA scan and serum creatinine. MATERIALS AND METHODS A total of 42 patients were enrolled in the study. All underwent DMSA scan before surgery and in 38 DMSA scan was done after unilateral nephrectomy. Serum creatinine was determined before and 1 year after surgery. The Student t test was used to determine statistical significance. Spearman rank core analysis was used to evaluate the association of calculated creatinine clearance time after surgery and renal absolute uptake before surgery. We performed 1-way ANOVA comparison of the means to determine the influence of age distribution on kidney hypertrophy and the increase in kidney uptake. RESULTS Average patient age was 61.5 years. Baseline mean creatinine clearance time was 71.5 ml. per minute, which decreased to 58.6 ml. per minute after nephrectomy (p <0.0001). Before surgery DMSA scan of the remaining kidney demonstrated an absolute uptake of 4.2% higher than that in the resected kidney (13.5% versus 9.35%, p = 0.0008). After nephrectomy the remaining kidney had an average increase of 3.9% of mean absolute uptake (17.7% versus 13.8%, p = 0.0001). Spearman rank core analysis demonstrated an association of higher preoperative absolute uptake in the remaining kidney with postoperatively high creatinine clearance time (r = 0.458, p = 0.003). Furthermore, 75% of patients with postoperative creatinine clearance time less than 40 ml. per minute presented with a preoperative absolute uptake of lower than 11% in the remaining kidney. In contrast, 75% of those with a postoperative creatinine clearance time of higher than 40 ml. per minute had a preoperative absolute uptake of higher than 11%. CONCLUSIONS A preoperative absolute uptake of lower than 11% in the remaining kidney was a significant risk factor for postoperative chronic renal insufficiency.


Urology | 2006

Sutureless nephron-sparing surgery: Use of albumin glutaraldehyde tissue adhesive (BioGlue)

Guy Hidas; Alexander Kastin; M. Mullerad; J. Shental; Boaz Moskovitz; Ofer Nativ


Urology | 2005

Comparison of nephron-sparing surgery in central versus peripheral renal tumors.

M. Mullerad; Alexander Kastin; Prasad S. Adusumilli; Boaz Moskovitz; Edmond Sabo; Ofer Nativ


Israel Medical Association Journal | 2002

Bladder tumor antigen stat test in non-urothelial malignant urologic conditions.

Moshe Wald; Sarel Halachmi; Gilad Amiel; Shahar Madjar; M. Mullerad; Ines Miselevitz; Boaz Moskovitz; Ofer Nativ


European Urology Supplements | 2005

781Does renal function change following percutaneous nephrolithotripsy (PCNL)? assessment with quantitative spect of Tc 99M-DSMA (QDMSA) renal scintigraphy

Boaz Moskovitz; Sarel Halachmi; M. Mullerad; V. Sopov; J. Burbara; N. Horev; David Groshar; Ofer Nativ


European Urology Supplements | 2017

Tailoring antibiotic prophylaxis for ureteroscopic procedures based on local resistance profiles may lead to reduced rates of infections and urosepsis

A. Zisman; S. Badaan; Alexander Kastin; Alexander Kravtsov; D. Kakiashvili; Gilad Amiel; M. Mullerad


European Urology Supplements | 2007

851 MORBIDITY OF OPEN NEPHRON SPARING SURGERY (NSS): A SINGLE INSTITUTION EXPERIENCE WITH OVER 250 CASES

R. Farfara; M. Mullerad; Z. Hirsch; Alexander Kastin; G. Meyer; Boaz Moskovitz; Ofer Nativ


Urology | 2006

MP-15.03

M. Mullerad; A. Kravtzov; G. Meyer; Alexander Kastin; M. Gross; K. Biton; I. Elias; M. Boaz; N. Ofer


Urology | 2006

MP-12.08: Nuclear morphometry for predicting outcome in patients with invasive bladder cancer following radical cystectomy

A. Kravtsov; Edmond Sabo; M. Mullerad; G. Meyer; M. Gross; E. Issaq; Boaz Moskovitz; Ofer Nativ


European Urology Supplements | 2006

LONG-TERM FOLLOW-UP OF ADRENOCORTICAL CARCINOMA PATIENTS TREATED WITH ADJUVANT LOW-DOSE MITOTANE (O, P', -DDD)

M. Mullerad; G. Dickstein; C. Shechner; G. Meyer; Boaz Moskovitz; Ofer Nativ

Collaboration


Dive into the M. Mullerad's collaboration.

Top Co-Authors

Avatar

Ofer Nativ

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Boaz Moskovitz

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Alexander Kastin

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

David Groshar

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Elias Issaq

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Edmond Sabo

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sarel Halachmi

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

Boaz Moskovits

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Guy Hidas

Technion – Israel Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge